Erratum: Use of probiotics for management of acute gastroenteritis: A position paper by the ESPGHAN working group for probiotics and prebiotics (Journal of Pediatric Gastroenterology and Nutrition (2014) 58 (531-539) DOI: 10.1097/MPG.0000000000000320);Use of probiotics for management of acute gastroenteritis: A position paper by the ESPGHAN working group for probiotics and prebiotics

Journal of Pediatric Gastroenterology and Nutrition

Volumn 58, Issue 4, 2014, Pages 531-539

  Szajewska, Hania ^a   Guarino, Alfredo ^b   Hojsak, Iva ^c   Indrio, Flavia ^d   Kolacek, Sanja ^c   Shamir, Raanan ^e   Vandenplas, Yvan ^f   Weizman, Zvi ^g  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^e TEL AVIV UNIVERSITY   (Israel)

^f UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^g BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

diarrhea; guideline; infants; microbiota; probiotics; RCT; systematic review

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

ACUTE GASTROENTERITIS; ARTICLE; BACILLUS PUMILUS; BACTERIAL STRAIN; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; CLOSTRIDIUM BUTYRICUM; DIARRHEA; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FECES ANALYSIS; HUMAN; INFANT; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS HELVETICUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHYDRATION; SACCHAROMYCES BOULARDII; SYSTEMATIC REVIEW (TOPIC); ACUTE DISEASE; BACILLUS; BIFIDOBACTERIUM; EVIDENCE BASED MEDICINE; GASTROENTERITIS; LACTOBACILLUS; SACCHAROMYCES;

ACUTE DISEASE; BACILLUS; BIFIDOBACTERIUM; EVIDENCE-BASED MEDICINE; GASTROENTERITIS; HUMANS; LACTOBACILLUS; PROBIOTICS; SACCHAROMYCES;

EID: 84897052017     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/01.mpg.0000476316.19682.dc     Document Type: Erratum

References (56)

1. Guarino A, Albano F, Ashkenazi S, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr 2008;46(Suppl 2):S81-122.
2. Food and Agriculture Organization of the United Nations. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. http://www.who.int/foodsafety/publications/fs-management/ en/probiotics.pdf. Accessed March 10, 2014.
3. Szajewska H, Skórka A, Ruszczyński M, et al. Meta-Analysis: Lactobacillus GG for treating acute gastroenteritis in children-updated analysis of randomised controlled trials. Aliment Pharmacol Ther 2013;38:467-76.
4. Szajewska H, Ruszczyński M, Kolacek S. Meta-Analysis shows limited for using Lactobacillus acidophilus LB to treat acute gastroenteritis in children. Acta Paediatr 2014;103:249-55.
5. Szajewska H, Urbańska M, Chmielewska A, et al. Meta-Analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benef Microbes 2014;Jan 24:1-9.
6. Higgins JPT, Altman DG, Sterne AC. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. www.cochrane-handbook. org. Accessed March 10, 2013.
7. Grześkowiak Ł, Isolauri E, Salminen S, et al. Manufacturing process influences properties of probiotic bacteria. Br J Nutr 2011; 105: 887-94.
8. Sanders ME, Guarner F, Guerrant R, et al. An update on the use and investigation of probiotics in health and disease. Gut 2013;62:787-96.
9. Szajewska H, Fordymacka A, Bardowski J, et al. Microbiological and genetic analysis of probiotic products licensed for medicinal purposes. Med Sci Monit 2004;10:BR346-50.
10. Hamilton-Miller JM, Shah S, Winkler JT. Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr 1999;2:223-9.
11. Hamilton-Miller JM, Shah S, Smith CT. "Probiotic" remedies are not what they seem. BMJ 1996;312:55-6.
12. Marcobal A, Underwood MA, Mills DA. Rapid determination of the bacterial composition of commercial probiotic products by terminal restriction fragment length polymorphism analysis. J Pediatr Gastroenterol Nutr 2008;46:608-11.
13. Masco L, Huys G, De Brandt E, et al. Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. Int J Food Microbiol 2005;102:221-30.
14. Dalby-Payne JR, Elliott EJ. Gastroenteritis in children. Clin Evid (Online) 2011;2011:pii: 0314.
15. Hempel S, Newberry S, Ruelaz A, et al. Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess (Full Rep) 2011:1-645.
16. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
17. Center for Drug Evaluation and Research; Center for Biologics Evaluation and Research. Guidance for industry: providing clinical evidence of effectiveness for human drug and biological products. http://www.fda. gov/downloads/Drugs%20/GuidanceComplianceRegulatoryInformation/Guidances/ ucm078749.pdf. Published May 1998. Accessed August 2013.
18. Szajewska H. Advances and limitations of evidence-based medicine-impact for probiotics. Ann Nutr Metab 2010;57 (suppl):6-9.
19. Rijkers GT, Bengmark S, Enck P, et al. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr 2010;140:S671-6.
20. Allen SJ, Martinez EG, Gregorio GV, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010CD003048.
21. Szajewska H, Skórka A. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-Analysis of randomized controlled trials. Aliment Pharmacol Ther 2009;30:955-63.
22. Dinleyici EC, Eren M, Ozen M, et al. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther 2012;12:395-410.
23. Chmielewska A, Ruszczyński M, Szajewska H. Lactobacillus reuteri strain ATCC 55730 for the treatment of acute infectious diarrhoea in children: a meta-Analysis of randomized controlled trials [Polish]. Pediatria Współczesna 2008;10:32-6.
24. Rosander A, Connolly E, Roos S. Removal of antibiotic resistance plasmids from Lactobacillus reuteri ATCC 55 730 and characterization of the resulting daughter strain, L reuteri DSM 17 938. Appl Environ Microbiol 2008;74:6032-40.
25. Egervärn M, Lindmark H, Olsson J, et al. Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans. Antonie Van Leeuwenhoek 2010;97:189-200.
26. Francavilla R, Lionetti E, Castellaneta S, et al. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea-A double-blind study. Aliment Pharmcol Ther 2012;36:363-9.
27. Dinleyici EC, Dalgic N, Guven S, et al. The effect of a Lactobacillus reuteri on the duration of diarrhea and length of hospital stay in children with acute diarrhea in Turkey: prospective, single blind, randomized controlled trial. http://www.espghan2013.org/docs/conference-files/46th-Annual-meeting-of- espghan-Abstracts. Accessed July 1, 2013.
28. Shornikova AV, Casas IA, Isolauri E, et al. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr 1997;24:399-404.
29. Shornikova AV, Casas IA, Mykkänen H, et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 1997;16:1103-7.
30. Eom TH, Oh EY, Kim YH, et al. The therapeutic effect of Lactobacillus reuteri in acute diarrhea in infants and toddlers [Korean]. Korean J Pediatr 2005;48:986-90.
31. Bellomo G, Mangiagle A, Nicastro L, et al. A controlled double-blind study of SF68 strain as a new biological preparation for the treatment of diarrhoea in pediatrics. Curr Ther Res 1980;28:927-35.
32. Bellomo G, Finocchiaro C, Frigerio G, et al. Controlled study of Enterococcus LAB strain SF68 in acute enteritis in children with concomitant respiratory infection [Studio controllato sull'enterococco L.A.B. ceppo SF 68 nelle enteriti acute del bambino concomitanti ad infezioni delle vie respiratorie]. Clin Pediatr 1982;64:219-27.
33. Bruno F, Frigerio G. A new therapeutic alternative for the treatment of enteritis-controlled double-blind tests with the strain SF 68 [Eine neuartige möglichkeit zur behandlung der enteritis-kontrollierte dop-pel- blindversuche mit dem Stamm SF 68]. Schweizerische Rundschau fur Medizin Praxis 1981;70:1717-20.
34. Bruno F, Nastasi A, Bruno M. Double-blind controlled study of the effect of the lactogenic enterococcus SF68 strain onvarious enterocolitis associated manifestations and on salmonella infections [Studio con-trollato dopio-cieco sull'effecto dell'enterococco lattoproduttore ceppo SF 68 su manifestazione associate a forme enterocolitiche variee a salmonellosi]. Clin Ter 1983;105:203-7.
35. Buydens P, Debeuckelaere S. Efficacy of SF68 in the treatment of acute diarrhea. A placebo-controlled trial. Scand J Gastroenterol 1996;31: 887-91.
36. Wunderlich PF, Braun L, Fumagalli I, et al. Double-blind report of the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-Associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 1989;17:333-8.
37. Canani RB, Cirillo P, Terrin G, et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 2007;335:340.
38. Lund B, Edlund C. Probiotic Enterococcus faecium strain is a possible recipient of the vanA gene cluster. Clin Infect Dis 2001; 32:1384-5.
39. Henker J, Laass M, Blokhin BM, et al. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur J Pediatr 2007;166:311-8.
40. Henker J, Laass MW, Blokhin BM, et al. Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers. Pediatr Infect Dis J 2008;27: 494-9.
41. Khanna V, Alam S, Malik A, et al. The efficacy of tyndalized Lacto-bacillus acidophilus in acute diarrhea. Indian J Pediatr 2005;72:935-8.
42. Rafeey M, Ostadrahimi A, Boniadi M, et al. Lacobacillus acidophilus yogurt and supplement in children with acute diarrhea: a clinical trial. Res J Med Sci 2008;2:13-8.
43. Kianifar HR, Farid R, Ahanchian H, et al. Probiotics in the treatment of acute diarrhea in young children. Iranian J Med Sci 2009;34:204-7.
44. Rerksuppaphol S, Rerksuppaphol L. Lactobacillus acidophilus and Bifidobacterium bifidum stored at ambient temperature are effective in the treatment of acute diarrhoea. Ann Trop Paediatr 2010;30:299-304.
45. Lee MC, Lin LH, Hung KL, et al. Oral bacterial therapy promotes recovery from acute diarrhea in children. Acta Paediatr Taiwan 2001; 42:301-5.
46. Vivatvakin B, Kowitdamrong E. Randomized control trial of live Lactobacillus acidophilus plus Bifidobacterium infantis in treatment of infantile acute watery diarrhea. J Med Assoc Thai 2006;89 (suppl 3): S126-33.
47. Sanders ME, Morelli L, Tompkins TA. Sporeformers as human probiotics: Bacillus, Sporolactobacillus, and Brevibacillus. Comp Rev Food Sci Food Saf 2003;2:101-10.
48. Mao M, Yu T, Xiong Y, et al. Effect of a lactose-free milk formula supplemented with bifidobacteria and streptococci on the recovery from acute diarrhoea. Asia Pac J Clin Nutr 2008;17:30-4.
49. Szymański H, Pejcz J, Jawień M, et al. Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains-A randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 2006;23:247-53.
50. Foster LM, Tompkins TA, Dahl WJ. A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011. Benef Microbes 2011;2:319-34.
51. Tlaskal P, Schramlova J, Kokesova A, et al. Probiotics in the treatment of diarrheal disease of children. NAFAS 2005;3:25-8.
52. Sarker SA, Sultana S, Fuchs GJ, et al. Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics 2005; 116:e221-8.
53. Huang YF, Liu PY, Chen YY, et al. Three-combination probiotics therapy in children with salmonella and rotavirus gastroenteritis. J Clin Gastroenterol 2014;48:37-42.
54. Dubey AP, Rajeshwari K, Chakravarty A, et al. Use of VSL#3 in the treatment of rotavirus diarrhea in children: preliminary results. J Clin Gastroenterol 2008;42 (suppl 3 pt 1):S126-9.
55. Grandy G, Medina M, Soria R, et al. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis 2010;10:253.
56. Payne DC, Vinjé J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013;368:1121-30.